OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Rationale design and synthesis of new apoptotic thiadiazole derivatives targeting VEGFR-2: computational and in vitro studies
Walid E. Elgammal, Hazem Elkady, Hazem A. Mahdy, et al.
RSC Advances (2023) Vol. 13, Iss. 51, pp. 35853-35876
Open Access | Times Cited: 6
Walid E. Elgammal, Hazem Elkady, Hazem A. Mahdy, et al.
RSC Advances (2023) Vol. 13, Iss. 51, pp. 35853-35876
Open Access | Times Cited: 6
Showing 6 citing articles:
Design and synthesis of thiadiazoles as anticancer, apoptotic, and VEGFR-2 inhibitors
Walid E. Elgammal, Hazem Elkady, Mohammed A. Dahab, et al.
Future Medicinal Chemistry (2025), pp. 1-13
Closed Access
Walid E. Elgammal, Hazem Elkady, Mohammed A. Dahab, et al.
Future Medicinal Chemistry (2025), pp. 1-13
Closed Access
Designing Novel Potent Oxindole Derivatives as VEGFR2 Inhibitors for Cancer Therapy: Computational Insights from Molecular Docking, Drug-likeness, DFT, and Structural Dynamics Studies
Sowmiya Perinbaraj, Manikandan Jayaraman, Jeyaraman Jeyakanthan, et al.
Journal of Molecular Graphics and Modelling (2025), pp. 109049-109049
Closed Access
Sowmiya Perinbaraj, Manikandan Jayaraman, Jeyaraman Jeyakanthan, et al.
Journal of Molecular Graphics and Modelling (2025), pp. 109049-109049
Closed Access
Design, synthesis, in vitro, and in silico studies of new thiadiazol derivatives as promising VEGFR-2 inhibitors and apoptosis inducers
Hazem A. Mahdy, Hazem Elkady, Walid E. Elgammal, et al.
Journal of Molecular Structure (2024) Vol. 1316, pp. 139019-139019
Closed Access | Times Cited: 2
Hazem A. Mahdy, Hazem Elkady, Walid E. Elgammal, et al.
Journal of Molecular Structure (2024) Vol. 1316, pp. 139019-139019
Closed Access | Times Cited: 2
Integrated in silico and in vitro discovery of a new anticancer thiadiazole analog targeting VEGFR-2
Ibrahim H. Eissa, Hazem Elkady, Walid E. Elgammal, et al.
Journal of Molecular Structure (2024) Vol. 1312, pp. 138641-138641
Closed Access | Times Cited: 1
Ibrahim H. Eissa, Hazem Elkady, Walid E. Elgammal, et al.
Journal of Molecular Structure (2024) Vol. 1312, pp. 138641-138641
Closed Access | Times Cited: 1
Anti-proliferative 2,3-dihydro-1,3,4-thiadiazoles targeting VEGFR-2: Design, synthesis, in vitro, and in silico studies
Hazem Elkady, Walid E. Elgammal, Hazem A. Mahdy, et al.
Computational Biology and Chemistry (2024) Vol. 113, pp. 108221-108221
Closed Access | Times Cited: 1
Hazem Elkady, Walid E. Elgammal, Hazem A. Mahdy, et al.
Computational Biology and Chemistry (2024) Vol. 113, pp. 108221-108221
Closed Access | Times Cited: 1
Design, synthesis, and evaluation of novel thiadiazole derivatives as potent VEGFR-2 inhibitors: a comprehensive in vitro and in silico study
Ibrahim H. Eissa, Walid E. Elgammal, Hazem A. Mahdy, et al.
RSC Advances (2024) Vol. 14, Iss. 48, pp. 35505-35519
Open Access
Ibrahim H. Eissa, Walid E. Elgammal, Hazem A. Mahdy, et al.
RSC Advances (2024) Vol. 14, Iss. 48, pp. 35505-35519
Open Access
Azole Derivatives: CuttingâEdge Agents in Cancer Therapy
Anuradha Mehra, Amit Mittal, Rekha Sangwan
ChemistrySelect (2024) Vol. 9, Iss. 43
Closed Access
Anuradha Mehra, Amit Mittal, Rekha Sangwan
ChemistrySelect (2024) Vol. 9, Iss. 43
Closed Access
Recent progress on anti-cancer activity of thiadiazoles: A review
CR Santhosh, Sampath Chinnam, Nagaraju Kottam, et al.
Results in Chemistry (2024), pp. 101939-101939
Open Access
CR Santhosh, Sampath Chinnam, Nagaraju Kottam, et al.
Results in Chemistry (2024), pp. 101939-101939
Open Access
